Literature DB >> 21935886

Posttranscriptional regulation of cancer traits by HuR.

Kotb Abdelmohsen1, Myriam Gorospe.   

Abstract

Cancer-related gene expression programs are strongly influenced by posttranscriptional mechanisms. The RNA-binding protein HuR is highly abundant in many cancers. Numerous HuR-regulated mRNAs encode proteins implicated in carcinogenesis. Here, we review the collections of HuR target mRNAs that encode proteins responsible for implementing five major cancer traits. By interacting with specific mRNA subsets, HuR enhances the levels of proteins that (1) promote cell proliferation, (2) increase cell survival, (3) elevate local angiogenesis, (4) help the cancer cell evade immune recognition, and (5) facilitate cancer cell invasion and metastasis. We propose that HuR exerts a tumorigenic function by enabling these cancer phenotypes. We discuss evidence that links HuR to several specific cancers and suggests its potential usefulness in cancer diagnosis, prognosis, and therapy.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21935886      PMCID: PMC3808850          DOI: 10.1002/wrna.4

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev RNA        ISSN: 1757-7004            Impact factor:   9.957


  173 in total

Review 1.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

2.  Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.

Authors:  J Yang; X Liu; K Bhalla; C N Kim; A M Ibrado; J Cai; T I Peng; D P Jones; X Wang
Journal:  Science       Date:  1997-02-21       Impact factor: 47.728

Review 3.  Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression.

Authors:  Y Hosokawa; A Arnold
Journal:  Genes Chromosomes Cancer       Date:  1998-05       Impact factor: 5.006

4.  Parallel and independent regulation of interleukin-3 mRNA turnover by phosphatidylinositol 3-kinase and p38 mitogen-activated protein kinase.

Authors:  X F Ming; G Stoecklin; M Lu; R Looser; C Moroni
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

Review 5.  Role of TGF-beta in immune-evasion of cancer.

Authors:  C Beck; H Schreiber; D Rowley
Journal:  Microsc Res Tech       Date:  2001-02-15       Impact factor: 2.769

Review 6.  Apoptotic signaling by c-MYC.

Authors:  B Hoffman; D A Liebermann
Journal:  Oncogene       Date:  2008-10-27       Impact factor: 9.867

Review 7.  Dual-specificity MAP kinase phosphatases (MKPs) and cancer.

Authors:  Stephen M Keyse
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

8.  Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR.

Authors:  Jodi M Saunus; Juliet D French; Stacey L Edwards; Dianne J Beveridge; Esme C Hatchell; Sarah A Wagner; Sandra R Stein; Andrew Davidson; Kaylene J Simpson; Glenn D Francis; Peter J Leedman; Melissa A Brown
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

Review 9.  Cellular senescence: its role in tumor suppression and aging.

Authors:  Naoko Ohtani; David J Mann; Eiji Hara
Journal:  Cancer Sci       Date:  2009-03-15       Impact factor: 6.716

Review 10.  The urokinase receptor as an entertainer of signal transduction.

Authors:  Silvia D'Alessio; Francesco Blasi
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01
View more
  212 in total

1.  PAR-CLIP analysis uncovers AUF1 impact on target RNA fate and genome integrity.

Authors:  Je-Hyun Yoon; Supriyo De; Subramanya Srikantan; Kotb Abdelmohsen; Ioannis Grammatikakis; Jiyoung Kim; Kyoung Mi Kim; Ji Heon Noh; Elizabeth J F White; Jennifer L Martindale; Xiaoling Yang; Min-Ju Kang; William H Wood; Nicole Noren Hooten; Michele K Evans; Kevin G Becker; Vidisha Tripathi; Kannanganattu V Prasanth; Gerald M Wilson; Thomas Tuschl; Nicholas T Ingolia; Markus Hafner; Myriam Gorospe
Journal:  Nat Commun       Date:  2014-11-04       Impact factor: 14.919

2.  The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2.

Authors:  Lisa E Young; Ashleigh E Moore; Lena Sokol; Nicole Meisner-Kober; Dan A Dixon
Journal:  Mol Cancer Res       Date:  2011-11-02       Impact factor: 5.852

3.  Senescence-associated microRNAs linked to tumorigenesis.

Authors:  Subramanya Srikantan; Myriam Gorospe; Kotb Abdelmohsen
Journal:  Cell Cycle       Date:  2011-10-01       Impact factor: 4.534

Review 4.  Regulation of senescence by microRNA biogenesis factors.

Authors:  Kotb Abdelmohsen; Subramanya Srikantan; Min-Ju Kang; Myriam Gorospe
Journal:  Ageing Res Rev       Date:  2012-01-28       Impact factor: 10.895

5.  Transcript stabilization by the RNA-binding protein HuR is regulated by cellular retinoic acid-binding protein 2.

Authors:  Amanda C Vreeland; Shuiliang Yu; Liraz Levi; Daniella de Barros Rossetto; Noa Noy
Journal:  Mol Cell Biol       Date:  2014-03-31       Impact factor: 4.272

Review 6.  MicroRNA and AU-rich element regulation of prostaglandin synthesis.

Authors:  Ashleigh E Moore; Lisa E Young; Dan A Dixon
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

7.  The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.

Authors:  F F Blanco; M Jimbo; J Wulfkuhle; I Gallagher; J Deng; L Enyenihi; N Meisner-Kober; E Londin; I Rigoutsos; J A Sawicki; M V Risbud; A K Witkiewicz; P A McCue; W Jiang; H Rui; C J Yeo; E Petricoin; J M Winter; J R Brody
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

8.  Changes in cellular mRNA stability, splicing, and polyadenylation through HuR protein sequestration by a cytoplasmic RNA virus.

Authors:  Michael D Barnhart; Stephanie L Moon; Alexander W Emch; Carol J Wilusz; Jeffrey Wilusz
Journal:  Cell Rep       Date:  2013-11-07       Impact factor: 9.423

9.  Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy.

Authors:  Samuel Slone; Sarah R Anthony; Xiaoqing Wu; Joshua B Benoit; Jeffrey Aube; Liang Xu; Michael Tranter
Journal:  Cell Signal       Date:  2016-08-10       Impact factor: 4.315

10.  Multi-leveled suppression of p53 function by HuR IncRNPs.

Authors:  Jen-Hao Yang; Myriam Gorospe
Journal:  Noncoding RNA Investig       Date:  2018-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.